Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: molecular analysis of the IDEAL/INTACT gefitinib trials by Bell Daphne W, Lynch Thomas J, Haserlat Sara M, Harris Patricia L, Okimoto Ross A, Brannigan Brian W, Sgroi Dennis C, Muir Beth, Riemenschneider Markus J, Iacona Renee Bailey, Krebs Annetta D, Johnson David H, Giaccone Giuseppe, Herbst Roy S, Manegold Christian, Fukuoka Masahiro, Kris Mark G, Baselga José, Ochs Judith S, Haber Daniel A in Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2005).

[PMID: 16204011] PubMed


Discussed In Paper


Variant Annotations

Sign in to see variant annotations.

Rx Annotations

No dosing information annotated.